The North America endoscopy guidewire market has been analyzed on the basis of three major countries — the US, Canada, and Mexico. The US is estimated to hold the largest share in the endoscopy guidewire market during the forecast period. ERCP is currently the procedure of choice for many biliary and pancreatic disorders. About 350000-500000 ERCP’s are currently performed annually in the United States. Common indications include choledocholithiasis, obstructive jaundice, biliary pancreatitis, malignant biliary obstruction, and benign biliary strictures; while uncommon indications include recurrent pancreatitis of unknown etiology, biliary or pancreatic duct leaks, pancreatic stones, pancreatic strictures, chronic pancreatitis, and sphincter of Oddi dysfunction. As per the data provided by, American Society of Clinical Oncology (ASCO) in 2021, an estimated 60,430 adults (31,950 men and 28,480 women) in the United States will be diagnosed with pancreatic cancer. The disease accounts for approximately 3% of all cancers. Pancreatic cancer is the eighth most common cancer in women and the tenth most common cancer in men. Incidence rates of pancreatic cancer have gone up by around 1% each year since 2000. It is estimated that 48,220 deaths (25,270 men and 22,950 women) from this disease will occur this year. It is the fourth leading cause of cancer death in both men and women. It accounts for 7% of all cancer deaths. The death rate has very slowly increased each year since 2000. Also, awareness and screening can enable to save 30,000 lives each year. Therefore, the American Society for Gastrointestinal Endoscopy (ASGE) in 2018, launched a campaign to inform the public about the link between chronic heartburn and esophageal adenocarcinoma, one of the fastest growing cancers in the US, and that due to recent advances in the detection and treatment of precancerous cells, gastroenterologists (GI's) are now better equipped to help prevent this cancer before it can even start
In the US, due to an increasing number of infected patients, healthcare professionals and leading organizations are distracting the flow of healthcare resources from research & development to primary care, which is slowing down the process of innovation. Gastrointestinal (GI) endoscopy centers are specialized units where thousands of endoscopies are performed annually. A significant proportion of these procedures are affected due to the national and regional lockdowns across the globe. To adapt to this rapidly evolving situation, endoscopy centers have undergone significant changes and have taken unprecedented precautions to avoid the transmission of the virus. However, endoscopy centers are going through financial strain due to a reduction in the number of procedures from lockdowns and fear of virus transmission. Theoretically, endoscopies could add to the disease transmission as SARS-CoV-2 has shown to be present in the GI secretions. Multiple precautions such as mandatory use of face masks, safe distancing, use of barriers between the endoscopists and patients, negative pressure rooms, extended use of personal protective equipment, and volume reduction have been taken to decrease the risk of disease transmission by these centers. Moreover, pre-endoscopy COVID-19 testing has now become the norm.
Strategic insights for the North America Endoscopy Guidewire provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 422.94 Million |
Market Size by 2028 | US$ 630.21 Million |
Global CAGR (2021 - 2028) | 5.9% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The geographic scope of the North America Endoscopy Guidewire refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The endoscopy guidewire market in North America is expected to grow from US$ 422.94 million in 2021 to US$ 630.21 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. Rising patient preference for minimally invasive procedures; Minimally invasive procedures are being performed widely during recent years. As a result, there has been a rise in number of people opting for minimally invasive surgeries. Unlike traditional clinical procedures such as open surgeries, minimally invasive procedures require only a small incision to be made at the site of the procedure. The small incision size facilitates speedy recovers compared to open procedures, reduces discomfort and risk of infection among patients. Moreover, the minimally invasive procedures include a few minor cuts; less trauma to the muscles, nerves, and tissues; less bleeding & scarring; minor trauma to organs; less pain; reduced use of narcotics; less hospital time; and negligible effect on the immune system. Minimally invasive surgeries such as endoscopy, laparoscopy, and robot-assisted surgery are opted by most of the health professionals owing to better results. For example, an instrument called an endoscope is inserted into the patient’s body through small incisions made in the body in endoscopy. This technique allows the physician to look inside the patient’s body and operate if needed. In laparoscopy, the surgical scars are minor, hospital stays are shorter, and the incisions created are much smaller, enabling faster healing and recovery. Moreover, in recent days, laparoscopy is being used widely for bariatric surgery and are economical compared to the traditional surgery method. Thus, the benefits and the accuracy offered by minimally invasive procedures are expected to provide broad growth opportunities to the players operating in the market. This is bolstering the growth of the endoscopy guidewire market.
Based on type, the market is segmented into monofilament, coiled, coated. In 2020, the coated segment held the largest share North America endoscopy guidewire market. Based on core material, the market is divided into stainless steel and nitinol. In 2020, the stainless steel segment held the largest share North America endoscopy guidewire market. Based on application, the market is segmented into diagnostics and therapeutic. In 2020, the therapeutic segment held the largest share North America endoscopy guidewire market.
A few major primary and secondary sources referred to for preparing this report on the endoscopy guidewire market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Boston Scientific Corporation
The North America Endoscopy Guidewire Market is valued at US$ 422.94 Million in 2021, it is projected to reach US$ 630.21 Million by 2028.
As per our report North America Endoscopy Guidewire Market, the market size is valued at US$ 422.94 Million in 2021, projecting it to reach US$ 630.21 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.
The North America Endoscopy Guidewire Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Endoscopy Guidewire Market report:
The North America Endoscopy Guidewire Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Endoscopy Guidewire Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Endoscopy Guidewire Market value chain can benefit from the information contained in a comprehensive market report.